EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Sequential Benznidazole–Vaccine–Benznidazole Regimen Enhances Therapeutic Efficacy Against Chronic Trypanosoma cruzi Infection in Mice

Paula Cacik, Estefanía Prochetto, Ulises Cha, María Florencia Pacini, Camila Bulfoni Balbi, Brenda Dinatale, Genaro Francisco Díaz, Florencia Belén González, Cecilia Farre, Ana Rosa Pérez, Iván Sergio Marcipar

Vaccines · 17.11.2026 · 14 (11) · 993

DOI: 10.3390/vaccines14110993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 17.11.2026. Verfasst von Paula Cacik und 10 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Argentine National Agency for the Promotion of Science and Technology, CAI+D 2020 PI Tipo II, CONICET PIP 0715.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Chronic Chagas cardiomyopathy (CCC), caused by Trypanosoma cruzi (T. cruzi), remains a major public health challenge and a leading cause of heart failure, with this chronic stage representing the period when most patients are diagnosed and require clinical intervention. However, the efficacy of the available parasiticidal drugs, benznidazole (BZL) and nifurtimox during chronic infection is limited and new therapeutic approaches are needed. In this study, we evaluated a novel sequential chemo-immunotherapeutic strategy (BZL → Vac → BZL) designed to shorten benznidazole treatment duration to minimize drug-related adverse effects by leveraging the synergistic potential of both treatments.

Methods

BALB/c mice chronically infected with T. cruzi were used as model. A long-term sequential regimen was evaluated and compared 190 days post-infection with uninfected, untreated infected (Tc), monotherapy (BZL or TSNt-ISPA vaccine), and combined (Vac → BZL) controls. The sequential treatment consisted of an initial short cycle of oral BZL, three subcutaneous immunizations with the TSNt-ISPA vaccine, and a final BZL booster. Cardiac parasite load and cytokine expression (qPCR), inflammation and fibrosis (histopathology), electrocardiograms (ECG), specific antibodies (ELISA), and splenic cellular response (flow cytometry) were analyzed.

Results

The BZL-Vac → BZL scheme significantly reduced cardiac parasite load, achieving undetectability in some animals. Combined therapies (Vac → BZL and BZL → Vac → BZL) significantly attenuated myocardial inflammation and fibrosis, improving P-wave duration and the QTc interval. The sequential treatment induced a robust Th1-associated humoral response (IgG2a) and a balanced cellular profile, uniquely increasing splenic IL-10-producing CD4+ T cells, TNF-α-producing CD8+ T cells, and cardiac IL-10 and Foxp3 expression.

Conclusions

The temporal integration of fractionated benznidazole and TSNt-ISPA immunotherapy protects myocardial integrity and function through an effector immune response under strict regulatory control.

Förderung

  • Argentine National Agency for the Promotion of Science and Technology
  • CAI+D 2020 PI Tipo II
  • CONICET PIP 0715
  • PID-UNR 2022
  • PID-UNR 1MED516

Zitieren

APA

Cacik, P., Prochetto, E., Cha, U., Pacini, M. F., Balbi, C. B., Dinatale, B., Díaz, G. F., González, F. B., Farre, C., Pérez, A. R., & Marcipar, I. S. (2026). A Sequential Benznidazole–Vaccine–Benznidazole Regimen Enhances Therapeutic Efficacy Against Chronic Trypanosoma cruzi Infection in Mice. Vaccines, 14(11), 993. https://doi.org/10.3390/vaccines14110993

Vancouver

Cacik P, Prochetto E, Cha U, Pacini MF, Balbi CB, Dinatale B, et al. A Sequential Benznidazole–Vaccine–Benznidazole Regimen Enhances Therapeutic Efficacy Against Chronic Trypanosoma cruzi Infection in Mice. Vaccines. 2026;14(11):993. doi:10.3390/vaccines14110993

BibTeX
@article{Cacik2026,
  author = {Cacik, Paula and Prochetto, Estefanía and Cha, Ulises and Pacini, María Florencia and Balbi, Camila Bulfoni and Dinatale, Brenda and Díaz, Genaro Francisco and González, Florencia Belén and Farre, Cecilia and Pérez, Ana Rosa and Marcipar, Iván Sergio},
  title = {A Sequential Benznidazole–Vaccine–Benznidazole Regimen Enhances Therapeutic Efficacy Against Chronic Trypanosoma cruzi Infection in Mice},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {11},
  pages = {993},
  doi = {10.3390/vaccines14110993}
}
Kostenlos starten →